We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

67 hedge funds and large institutions have $8.6M invested in Tvardi Therapeutics in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

0% more funds holding

Funds holding: 67 → 67 (0)

1.3% less ownership

Funds ownership: 30.11% → 28.82% (-1.3%)

29% less capital invested

Capital invested by funds: $12.1M → $8.6M (-$3.52M)

Holders
67
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
20
Reduced
17
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
+$165K
2
GLA
Great Lakes Advisors
Illinois
+$142K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$98.8K
4
UBS Group
UBS Group
Switzerland
+$58.4K
5
Russell Investments Group
Russell Investments Group
United Kingdom
+$28.8K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$204K
2
Bank of America
Bank of America
North Carolina
-$109K
3
QC
Quadrature Capital
United Kingdom
-$90.1K
4
FCM
Farallon Capital Management
California
-$85.4K
5
Squarepoint
Squarepoint
New York
-$74.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
ME
51
McIlrath & Eck
Washington
$64 – – –
HI
52
Harbour Investments
Wisconsin
$48 – – –
MCM
53
MAI Capital Management
Ohio
$45 +$16 +4 +40%
LSA
54
Leonteq Securities AG
Switzerland
$38 – – –
RIL
55
Rothschild Investment LLC
Illinois
$38 +$47 +12 New
RFP
56
Root Financial Partners
California
$32 +$39 +10 New
TWD
57
True Wealth Design
Ohio
$29 +$35 +9 New
WPA
58
Wealth Preservation Advisors
Tennessee
$25 +$31 +8 New
IAIM
59
International Assets Investment Management
Florida
$18 – – –
SS
60
SBI Securities
Japan
$16 +$4 +1 +25%
TC
61
Truvestments Capital
Florida
$13 – – –
Osaic Holdings
62
Osaic Holdings
Arizona
$6 -$106 -27 -93%
LFG
63
Larson Financial Group
Missouri
$6 – – –
SIS
64
Sound Income Strategies
Florida
$6 – – –
SIC
65
SJS Investment Consulting
Ohio
$4 +$4 +1 New
Fifth Third Bancorp
66
Fifth Third Bancorp
Ohio
$3 +$4 +1 New
Jane Street
67
Jane Street
New York
– -$204K -47,444 Closed
Bank of America
68
Bank of America
North Carolina
– -$109K -25,382 Closed
QC
69
Quadrature Capital
United Kingdom
– -$90.1K -20,964 Closed
XT
70
XTX Topco
Cayman Islands
– -$55.2K -12,838 Closed
HF
71
HRT Financial
New York
– -$47K -11,050 Closed
Two Sigma Investments
72
Two Sigma Investments
New York
– -$45.1K -10,492 Closed
Simplex Trading
73
Simplex Trading
Illinois
– -$6.1K -1,418 Closed
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
– -$1.42K -331 Closed
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
– -$819 -209 -71%
1 2
3
4

TVRD Hedge Fund Activity: Q1 2026 in Review

67 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q1 2026, worth a combined $8.6M — down 29% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TVRD positions and 12 closed out — a net gain of 2 holders — while 20 added to existing stakes and 17 trimmed.

The largest buyer was AQR Capital Management, opening a new position worth an estimated $165K. The largest seller was Jane Street, exiting entirely with an estimated $204K sold.

  • 67 institutional investors held Tvardi Therapeutics (TVRD) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $8.6M of Tvardi Therapeutics stock for Q1 2026, down 29% quarter-over-quarter.
  • 14 funds opened new Tvardi Therapeutics positions in Q1 2026 and 12 closed out, a net change of +2 holders.
  • The largest Tvardi Therapeutics buyer in Q1 2026 was AQR Capital Management, an estimated $165K added.
  • The largest Tvardi Therapeutics seller in Q1 2026 was Jane Street, an estimated $204K sold.

Based on aggregated 13F filings for Q1 2026.